Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...

The Network Replacement Project (NRP) team is pleased to announce the successful completion of a crucial phase in the ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

Nearly one in five condo buildings in County have failed to undergo required Florida safety-inspection reports.

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) and keeping the ...

Nearly one in five condo buildings in Palm Beach County have failed to undergo required safety-inspection reports.

J.P. Small Memorial Park in Durkeeville is getting a multimillion dollar upgrade, fueling "Field of Dreams" hopes for a Major ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Aduro Clean Technologies, Inc. (Sarnia, Ont., Canada) announced the successful completion of the Basic Engineering Design phase for its Hydrochemolytic ...

Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

Aduro Clean Technologies Inc., a clean technology company using the power of chemistry to transform lower value feedstocks, ...

The Tennessee Valley Authority (TVA) has selected Bechtel, Sargent & Lundy, and GE Hitachi to spearhead the initial planning ...